2007
DOI: 10.1016/j.jconrel.2007.05.026
|View full text |Cite
|
Sign up to set email alerts
|

Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
96
0
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 194 publications
(104 citation statements)
references
References 37 publications
1
96
0
1
Order By: Relevance
“…20 WGA-modified nanoparticles could also be delivered to the brain after intranasal administration via the nose-brain transport pathway. 21 Since the pathogenesis of AD is in the central nervous system (CNS), the use of CL-conjugated LIP (CL/LIP) modified with WGA (WGA-CL/LIP) may benefit AD management.…”
Section: Introductionmentioning
confidence: 99%
“…20 WGA-modified nanoparticles could also be delivered to the brain after intranasal administration via the nose-brain transport pathway. 21 Since the pathogenesis of AD is in the central nervous system (CNS), the use of CL-conjugated LIP (CL/LIP) modified with WGA (WGA-CL/LIP) may benefit AD management.…”
Section: Introductionmentioning
confidence: 99%
“…For example, chitosan modified molecules showed much longer residency time on the olfactory epithelium (Charlton et al 2007), as well as enhanced permeability due to their interaction with tight junction complexes (Smith et al 2004). Additionally, PEG coated nanoparticles showed increased diffusion in tissues (Lai et al 2007), and lectins isolated from plants could greatly upregulate the uptake of coated nanoparticles without clear evidences of toxicity (Gao et al 2006;Gao et al 2007). It is hoped that other small molecules and peptides, such as cholera toxin subunit B (CTB) (Zhang et al 2008), could provide more possibilities in further improvement of nanoparticles based intranasal drug delivery.…”
Section: Intranasal Deliverymentioning
confidence: 99%
“…10 However, low permeability across the In addition, wheat germ agglutinin (WGA) has distinct carbohydrate specificity and can be efficient in delivery of pharmaceuticals across the blood-brain barrier. 21 In a lectin-mediated targeting study, WGA was found to have a strong interaction with human ECV304, a human bladder carcinoma-derived epithelial cell line for mimicking the blood-brain barrier, and to generate only a slight variation in glycosylation pattern. 22 The aim of this study was to investigate the ability of WGA-conjugated and CL-incorporated liposomes (WGA-CL-liposomes) to encapsulate nerve-inductive NGF and antiinflammatory CUR for AD therapy.…”
Section: Introductionmentioning
confidence: 99%